In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis (Q35685125)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2003

Language	Label	Description	Also known as
English	In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis	scientific article published on September 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ellie J. C. Goldstein

1

object named as

Ellie J C Goldstein

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Kerin L. Tyrrell

5

object named as

Kerin L Tyrrell

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Diane M. Citron

2

object named as

Diane M Citron

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C. Vreni Merriam

3

object named as

C Vreni Merriam

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

4

object named as

Yumi A Warren

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Helen T Fernandez

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

3008-3011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Anaerobic bacteria in upper respiratory tract and other head and neck infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Bacteriological findings of acute maxillary sinusitis in young adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

12 July 2018

Widespread use of fluoroquinolones versus emerging resistance in pneumococci

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

25 September 2018

Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

25 September 2018

Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182602

25 September 2018

Identifiers

10.1128/AAC.47.9.3008-3011.2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35685125&oldid=2068568372"